"Hyaluronan Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.
| Descriptor ID |
D018960
|
| MeSH Number(s) |
D09.698.735.200.625 D12.776.395.550.200.625.144 D12.776.395.650.750.281 D12.776.543.550.200.625.144 D12.776.543.750.705.877.144 D23.050.301.350.625.144
|
| Concept/Terms |
Hyaluronan Receptors- Hyaluronan Receptors
- Hyaluronic Acid Binding Protein
- Hyaluronan-Binding Protein
- Hyaluronan Binding Protein
- CD44 Antigen
- Antigen, CD44
- Receptors, Hyaluronan
- Antigens, CD44
- Hyaluronan Receptor
- Receptor, Hyaluronan
- Chondroitin Sulfate Proteoglycan 8
- CD44 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Hyaluronan Receptors".
Below are MeSH descriptors whose meaning is more specific than "Hyaluronan Receptors".
This graph shows the total number of publications written about "Hyaluronan Receptors" by people in this website by year, and whether "Hyaluronan Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 3 | 4 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 3 | 4 |
| 2003 | 1 | 1 | 2 |
| 2004 | 3 | 1 | 4 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 5 | 6 |
| 2008 | 4 | 4 | 8 |
| 2009 | 1 | 7 | 8 |
| 2010 | 2 | 5 | 7 |
| 2011 | 5 | 9 | 14 |
| 2012 | 3 | 6 | 9 |
| 2013 | 6 | 9 | 15 |
| 2014 | 1 | 4 | 5 |
| 2015 | 3 | 5 | 8 |
| 2016 | 4 | 6 | 10 |
| 2017 | 1 | 6 | 7 |
| 2018 | 6 | 1 | 7 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 3 | 3 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyaluronan Receptors" by people in Profiles.
-
CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice. J Control Release. 2022 09; 349:796-811.
-
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL. Leukemia. 2022 05; 36(5):1261-1273.
-
Immunologic Roles of Hyaluronan in Dermal Wound Healing. Biomolecules. 2021 08 18; 11(8).
-
MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Sci Rep. 2021 04 28; 11(1):9219.
-
Inhibitors of metalloprotease, ?-sectretase, protein kinase C and Rho kinase inhibit wild-type adenoviral replication. PLoS One. 2020; 15(7):e0236175.
-
Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy. Biomater Sci. 2020 May 21; 8(10):2939-2954.
-
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Mol Ther. 2020 05 06; 28(5):1251-1262.
-
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment. J Clin Invest. 2019 05 01; 129(5):1878-1894.
-
CD44 splice isoform switching determines breast cancer stem cell state. Genes Dev. 2019 02 01; 33(3-4):166-179.
-
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer. Drug Deliv. 2018 Nov; 25(1):1394-1402.